Get startedLog in
    Picture of Aclaris Therapeutics logo

    ACRS — Aclaris Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapMomentum Trap
    All News

    Brief: Aclaris Therapeutics Announces Sale Of Olumiant Royalties And Milestones To Omers Life Sciences For Up To $31.5 Million

    Picture of Aclaris Therapeutics logoAclaris Therapeutics
    16/07/2024 21:11
    July 16 (Reuters) - Aclaris Therapeutics Inc  ACRS.O :
    * ACLARIS THERAPEUTICS ANNOUNCES SALE OF OLUMIANT® ROYALTIES
AND
MILESTONES TO OMERS LIFE SCIENCES FOR UP TO $31.5 MILLION
    * ACLARIS THERAPEUTICS INC - RECEIVES $26.5M UPFRONT PAYMENT

Source text for Eikon:  ID:nGNX3LbYzF 
Further company coverage:  ACRS.O 

 ((Reuters.Brief@thomsonreuters.com;))

    Recent news on Aclaris Therapeutics

    See all news